Curatis Holding AG (CHIX:CURNZ) FCF Yield % : -6.61 (As of Jun. 21, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Curatis Holding AG's Trailing 12-Month Free Cash Flow is CHF-1.89 Mil, and Market Cap is CHF28.50 Mil. Therefore, Curatis Holding AG's FCF Yield % for today is -6.61%.

The historical rank and industry rank for Curatis Holding AG's FCF Yield % or its related term are showing as below:

CHIX:CURNz' s FCF Yield % Range Over the Past 10 Years
Min: -4010.24 Med: 0 Max: 0
Current: -6.61

CHIX:CURNz's FCF Yield % is ranked worse than
69.42% of 1079 companies
in the Drug Manufacturers industry
Industry Median: -0.15 vs CHIX:CURNz: -6.61

Curatis Holding AG's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Curatis Holding AG FCF Yield % Historical Data

The historical data trend for Curatis Holding AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG FCF Yield % Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

-0.28

-31.62

-362.00

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-0.36	-5.39	-47.82	-26.34	-120.60

Competitive Comparison of Curatis Holding AG's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's FCF Yield % falls into.

Curatis Holding AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Curatis Holding AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.885	/	0.52071936
	=	-362.00%

Curatis Holding AG's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.314	*	2	/	0.52071936
	=	-120.60%

Curatis Holding AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Curatis Holding AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG (CHIX:CURNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

CURN:Switzerland

Address

Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057

Website

https://www.kinarus.com

Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG (CHIX:CURNZ) Headlines

No Headlines